The team conducted an extensive evaluation to clarify whether the presence of TPO antibodies contributes to cardiovascular ...
Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today ...
Background: The suppressive effects of immune checkpoint inhibitors (ICIs) on anti-tumor immunity have been well documented. However, ICIs can enhance immune responses and trigger autoimmune-related ...
The MarketWatch News Department was not involved in the creation of this content. -- Collaboration to focus on building a leading, US-based biotech dedicated to addressing underserved patients ...
Collaboration to focus on building a leading, US-based biotech dedicated to addressing underserved patients impacted by autoimmune and endocrinology disorders GenSci to receive $70 million ...
Shanghai Scizeng Medical Technology Co., LTD, a subsidiary of Changchun GeneScience Pharmaceutical Co., Ltd. ("GenSci"), RTW Investments, LP ("RTW"), and Yarrow Bioscience, Inc. ("Yarrow") today ...
SHANGHAI and HANGZHOU, China, Dec. 15, 2025 /PRNewswire/ -- Minghui Pharmaceutical, a late-stage biopharmaceutical company dedicated to developing transformative medicines in immunology and oncology, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback